Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting

References

• Radhakrishnan V, Kapoor G, Arora B, et al. Management of Hodgkins lymphoma: ICMR consensus document. Indian J Pediatr. 2017;84(5):371–381. doi:10.1007/s12098-017-2304-6.
   PubMed Web of Science ®Google Scholar
• Mauz-Körholz C, Hasenclever D, Dörffel W, et al. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study. J Clin Oncol. 2010;28(23):3680–3686. doi:10.1200/JCO.2009.26.9381.
   PubMed Web of Science ®Google Scholar
• Euronet Hodgkin Lymphoma Protocol. Accessed July 2, 2018. Available at: https://www.skion.nl/workspace/uploads/EuroNet-PHL-Interim-TreatmentGuidelines-2012-12-3v0-2.pdf.
   Google Scholar
• Trehan A, Singla S, Marwaha RK, Bansal D, Srinivasan R. Hodgkin lymphoma in children: experience in a tertiary care centre in India. J Pediatr Hematol Oncol. 2013;35(3):174–179. doi:10.1097/MPH.0b013e318271f587.
   PubMed Web of Science ®Google Scholar
• Mittal A, Bhethanabhotla S, Ganguly S, et al. Late effects in pediatric Hodgkin lymphoma survivors after uniform treatment with ABVD with or without radiotherapy. Pediatr Blood Cancer. 2021;68(11):e29293. doi:10.1002/pbc.29293.
   PubMed Web of Science ®Google Scholar
• Mahajan A, Singh M, Bakhshi S, et al. Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experience. Pediatr Blood Cancer. 2021;68(10):e29219.
   PubMed Web of Science ®Google Scholar
• Terezakis SA, Metzger ML, Hodgson DC, et al. ACR appropriateness criteria pediatric Hodgkin lymphoma. Pediatr Blood Cancer. 2014;61(7):1305–1312. doi:10.1002/pbc.24983.
   PubMed Web of Science ®Google Scholar
• Agrawal K, Mittal BR, Bansal D, et al. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin’s lymphoma. Ann Nucl Med. 2013;27(2):146–151. doi:10.1007/s12149-012-0665-5.
   PubMed Web of Science ®Google Scholar
• Olweny CL. Cotswolds modification of the Ann Arbor staging system for Hodgkin’s disease. J Clin Oncol. 1990;8:1598.
   PubMed Web of Science ®Google Scholar
• Gupta S, Yeh S, Martiniuk A, et al. The magnitude and predictors of abandonment of therapy in paediatric acute leukaemia in middle-income countries: a systematic review and meta-analysis. Eur J Cancer. 2013;49(11):2555–2564. doi:10.1016/j.ejca.2013.03.024.
   PubMed Web of Science ®Google Scholar
• WHO AnthroPlus for Personal Computers: Software for Assessing Growth of the World’s Children and Adolescents. Geneva: WHO. 2009. http://www.who.int/growthref/tools/en/. Accessed January 12, 2020.
   Google Scholar
• WHO Global Database on Child Growth and Malnutrition. Geneva: WHO; 2016. Accessed January 12, 2020. http://www.who.int/nutgrowthdb/about/introduction/en/.
   Google Scholar
• Das A, Chatterjee D, Mittal BR, Mukherjee KK, Radotra B, Bansal D. Central nervous system relapse in Hodgkin lymphoma: successful treatment without radiotherapy. Pediatr Blood Cancer. 2017;64(4):e26277. doi:10.1002/pbc.26277.
   Web of Science ®Google Scholar
• Parambil BC, Narula G, Prasad M, et al. Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India. Pediatr Blood Cancer. 2020;67(2):e28058. doi:10.1002/pbc.28058.
   PubMed Web of Science ®Google Scholar
• Jain S, Kapoor G, Bajpai R. ABVD-based therapy for Hodgkin lymphoma in children and adolescents: lessons learnt in a tertiary care oncology center in a developing country. Pediatr Blood Cancer. 2016;63(6):1024–1030. doi:10.1002/pbc.25935.
   PubMed Web of Science ®Google Scholar
• Verma Md N, Kumar Md A. Treating Hodgkin’s lymphoma in a resource poor setting: challenges and outcome. cor. 2015;3(2):11–16. doi:10.13189/cor.2015.030201.
   Google Scholar
• Seth R, Das RR, Puri K, Singh P. Clinical profile and chemotherapy response in children with Hodgkin lymphoma at a tertiary care centre. J Clin Diagn Res. 2015;9:SC25–30.
   PubMedGoogle Scholar
• Arya LS, Dinand V, Thavaraj V, et al. Hodgkin’s disease in Indian children: outcome with chemotherapy alone. Pediatr Blood Cancer. 2006;46(1):26–34. doi:10.1002/pbc.20157.
   PubMed Web of Science ®Google Scholar
• Friedman DL, Chen L, Wolden S, et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children’s Oncology Group Study AHOD0031. JCO. 2014;32(32):3651–3658. doi:10.1200/JCO.2013.52.5410.
   PubMed Web of Science ®Google Scholar
• Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46(4):264–273. doi:10.4103/0019-509X.55546.
   PubMedGoogle Scholar
• Zubizarreta PA, Alfaro E, Guitter M, et al. Children and adolescent Hodgkin lymphoma in Argentina: long-term results after combined ABVD and restricted radiotherapy. J Pediatr Hematol Oncol. 2017;39(8):602–608. doi:10.1097/MPH.0000000000000943.
   PubMed Web of Science ®Google Scholar
• Sherief LM, Elsafy UR, Abdelkhalek ER, et al. Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country. Medicine (Baltimore)). 2015;94(15):e670. doi:10.1097/MD.0000000000000670.
   PubMed Web of Science ®Google Scholar
• Geel JA, Chirwa TC, Rowe B, for the South African Children’s Cancer Study Group, et al. South African Children’s Cancer Study Group. treatment outcomes of children with Hodgkin lymphoma between 2000 and 2010: first report by the South African Children’s Cancer Study Group. Pediatr Blood Cancer. 2017;64(10):e26536. doi:10.1002/pbc.26536.
   Web of Science ®Google Scholar
• Ghafoor T. Prognostic factors in pediatric Hodgkin lymphoma: experience from a developing country. Leuk Lymphoma. 2020;61(2):344–350. doi:10.1080/10428194.2019.1665666.
   PubMed Web of Science ®Google Scholar
• Castellanos EM, Barrantes JC, Báez LF, et al. A chemotherapy only therapeutic approach to pediatric Hodgkin lymphoma: AHOPCA LH 1999. Pediatr Blood Cancer. 2014;61(6):997–1002. doi:10.1002/pbc.24905.
   PubMed Web of Science ®Google Scholar
• Dörffel W, Rühl U, Lüders H, et al. Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95. JCO. 2013;31(12):1562–1568. doi:10.1200/JCO.2012.45.3266.
   PubMed Web of Science ®Google Scholar
• Giulino-Roth L, Pei Q, Buxton A, et al. Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children’s Oncology Group. Blood. 2021;137(11):1449–1456. doi:10.1182/blood.2020007225.
   PubMed Web of Science ®Google Scholar
• Prasad M, Dhamankar V, Goswami S, et al. Late effects in long-term survivors of childhood Hodgkin lymphoma: a single-centre experience. 46th Congress of the International Society of Paediatric Oncology (SIOP) 2014. Accessed August 27, 2021. https://www.reasearchgate.net/publication/274953838_Late_Effects_in_Long_term_Survivors_of_Childhood_Hodgkin_Lymphoma_A_Single_Centre_Experience.
   Google Scholar
• Büyükkapu-Bay S, Çorapçıoğlu F, Aksu G, Anık Y, Demir H, Erçin C. Prognostic factors and treatment results of pediatric Hodgkin’s lymphoma: a single center experience. Turk J Pediatr. 2015;57(4):359–366.
   PubMed Web of Science ®Google Scholar